DK3260865T3 - Fremgangsmåde til behandling af blod, blodprodukter og organer - Google Patents
Fremgangsmåde til behandling af blod, blodprodukter og organer Download PDFInfo
- Publication number
- DK3260865T3 DK3260865T3 DK17172222.6T DK17172222T DK3260865T3 DK 3260865 T3 DK3260865 T3 DK 3260865T3 DK 17172222 T DK17172222 T DK 17172222T DK 3260865 T3 DK3260865 T3 DK 3260865T3
- Authority
- DK
- Denmark
- Prior art keywords
- blood
- organs
- procedure
- treatment
- products
- Prior art date
Links
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 239000010836 blood and blood product Substances 0.000 title 1
- 229940125691 blood product Drugs 0.000 title 1
- 210000000056 organ Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Physiology (AREA)
- Microbiology (AREA)
- Obesity (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE201210102999 DE102012102999A1 (de) | 2012-04-05 | 2012-04-05 | Verfahren zur Behandlung von Blut, Blutprodukten und Organen |
| DE102012108598.6A DE102012108598A1 (de) | 2012-09-14 | 2012-09-14 | Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung |
| DE102012108599.4A DE102012108599B4 (de) | 2012-09-14 | 2012-09-14 | A-Beta-Oligomer-bindende Peptide und deren Verwendung |
| EP13718522.9A EP2834643B1 (de) | 2012-04-05 | 2013-04-05 | Verfahren zur behandlung von blut, blutprodukten und organen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3260865T3 true DK3260865T3 (da) | 2023-02-27 |
| DK3260865T5 DK3260865T5 (da) | 2024-10-14 |
Family
ID=48184148
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17172222.6T DK3260865T5 (da) | 2012-04-05 | 2013-04-05 | Fremgangsmåde til behandling af blod, blodprodukter og organer |
| DK13718522.9T DK2834643T3 (da) | 2012-04-05 | 2013-04-05 | Fremgangsmåde til behandling af blod, blodprodukter og organer |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13718522.9T DK2834643T3 (da) | 2012-04-05 | 2013-04-05 | Fremgangsmåde til behandling af blod, blodprodukter og organer |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US9591845B2 (da) |
| EP (2) | EP3260865B1 (da) |
| JP (3) | JP2015518474A (da) |
| CN (2) | CN104380110A (da) |
| DK (2) | DK3260865T5 (da) |
| ES (2) | ES2773125T3 (da) |
| PL (1) | PL3260865T3 (da) |
| WO (1) | WO2013150126A2 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104380111B (zh) | 2012-04-05 | 2017-08-29 | 于利希研究中心有限公司 | 包含多价结合淀粉样β蛋白的D‑肽的聚合物及其应用 |
| DE102012108598A1 (de) * | 2012-09-14 | 2014-04-10 | Forschungszentrum Jülich GmbH | Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung |
| US9591845B2 (en) * | 2012-04-05 | 2017-03-14 | Forschungszentrum Juelich Gmbh | Method for treating blood, blood products and organs |
| DE102013016002A1 (de) * | 2013-09-26 | 2015-03-26 | Forschungszentrum Jülich GmbH | Zyklische, Amyloid-Beta-bindende Peptide und deren Verwendung |
| JP6660877B2 (ja) | 2013-09-26 | 2020-03-11 | フォルシュングスツェントルム・ユーリッヒ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | アミロイド−β−結合性ペプチド、ならびにアルツハイマー型認知症の治療および診断のためのその使用 |
| DE102015003676A1 (de) | 2015-03-20 | 2016-09-22 | Forschungszentrum Jülich GmbH Fachbereich Patente | Spezifisch A-Beta Spezies bindende Peptide für die Therapie und/oder die Diagnose der Alzheimerschen Demenz |
| CN109475512A (zh) * | 2016-07-06 | 2019-03-15 | 乔治·斯特彻夫 | 植物提取装置和方法 |
| CN112088023B (zh) | 2018-01-05 | 2024-05-14 | 帕斯艾克斯公司 | 用于捕获和去除流体中的疾病物质的装置 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2214247C (en) | 1995-03-14 | 2004-02-10 | Praecis Pharmaceuticals Incorporated | Modulators of amyloid aggregation |
| US5968820A (en) | 1997-02-26 | 1999-10-19 | The Cleveland Clinic Foundation | Method for magnetically separating cells into fractionated flow streams |
| WO2000063268A1 (en) | 1999-04-16 | 2000-10-26 | Wm. Marsh Rice University | Poly(propylene fumarate) cross linked with poly(ethylene glycol) |
| DK1346041T3 (da) | 2000-11-27 | 2007-07-02 | Praecis Pharm Inc | Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom |
| DE10117281A1 (de) | 2001-04-06 | 2002-10-24 | Inst Molekulare Biotechnologie | Peptid zur Diagnose und Therapie der Alzheimer-Demenz |
| US20040143093A1 (en) * | 2002-07-11 | 2004-07-22 | Ralph Zahn | Method for inducing a conformational transition in proteins, such as pathogenic/infectious proteins, and their use |
| WO2004056318A2 (en) * | 2002-12-19 | 2004-07-08 | New York University | Method for treating amyloid disease |
| US20050158306A1 (en) | 2004-01-16 | 2005-07-21 | Halikas James A. | Treatment for neuro-degenerative disease by a blood cleansing system using monoclonal antibodies |
| AT500483B1 (de) | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| DE102005009909A1 (de) | 2005-03-01 | 2006-09-07 | Heinrich-Heine-Universität Düsseldorf | Verbindungen geeignet zur Beseitigung fehlgefalteter Proteine |
| DE102005031429A1 (de) | 2005-07-04 | 2007-01-11 | Heinrich-Heine-Universität Düsseldorf | Verfahren zur selektiven Bestimmung pathologischer Proteinablagerungen |
| DE102005063175A1 (de) | 2005-07-29 | 2007-02-01 | Hans-Werner Prof. Dr. Heinrich | Vorrichtung und Verfahren zum Isolieren von Zellen, Biopartikeln und/oder Molekülen aus Flüssigkeiten mit dem Ziel einer Anwendung für Tiere, in der Biotechnologie (einschließlich der biologischen Forschung) und der medizinischen Diagnostik |
| US20070092508A1 (en) * | 2005-10-21 | 2007-04-26 | Recombiant Technologies, Llc | Detoxification depot for Alzheimer's disease |
| DE102006015140A1 (de) | 2006-03-31 | 2007-10-11 | Philipps-Universität Marburg | Heterozyklische Verbindungen mit Wirkung gegen neurodegenerative Erkrankungen |
| CA2681766A1 (en) | 2007-03-23 | 2008-10-02 | The Governors Of The University Of Alberta | Multivalent heterobifunctional polymers and methods of their use |
| CN101538329B (zh) * | 2008-03-20 | 2013-01-30 | 中国医学科学院基础医学研究所 | 新的抗β-淀粉样多肽抗体的可变区序列及其编码序列 |
| WO2010062570A2 (en) * | 2008-10-27 | 2010-06-03 | Recombinant Technologies Llc | COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE |
| DE102008037564A1 (de) * | 2008-11-19 | 2010-05-20 | Forschungszentrum Jülich GmbH | Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden |
| DE102009037015A1 (de) | 2009-08-07 | 2011-02-17 | Michael Hajek | Vorrichtung und Verfahren zur Eliminierung von bioschädlichen Stoffen aus Körperflüssigkeiten |
| DE102010019336A1 (de) | 2010-05-05 | 2011-11-10 | Forschungszentrum Jülich GmbH | Mittel zur Behandlung der Alzheimerschen Demenz |
| DE102010017130B4 (de) | 2010-05-28 | 2018-11-29 | Forschungszentrum Jülich GmbH | Hybrid-Verbindung, deren Verwendung und Verfahren zu deren Herstellung |
| CN102233128B (zh) * | 2010-11-26 | 2013-04-17 | 王延江 | 一种p75NTR-ECD在防治阿尔茨海默病药物中应用 |
| US9591845B2 (en) | 2012-04-05 | 2017-03-14 | Forschungszentrum Juelich Gmbh | Method for treating blood, blood products and organs |
| CN104380111B (zh) * | 2012-04-05 | 2017-08-29 | 于利希研究中心有限公司 | 包含多价结合淀粉样β蛋白的D‑肽的聚合物及其应用 |
-
2013
- 2013-04-05 US US14/388,865 patent/US9591845B2/en active Active
- 2013-04-05 EP EP17172222.6A patent/EP3260865B1/de active Active
- 2013-04-05 EP EP13718522.9A patent/EP2834643B1/de active Active
- 2013-04-05 DK DK17172222.6T patent/DK3260865T5/da active
- 2013-04-05 CN CN201380018312.9A patent/CN104380110A/zh active Pending
- 2013-04-05 DK DK13718522.9T patent/DK2834643T3/da active
- 2013-04-05 PL PL17172222.6T patent/PL3260865T3/pl unknown
- 2013-04-05 JP JP2015503890A patent/JP2015518474A/ja active Pending
- 2013-04-05 WO PCT/EP2013/057160 patent/WO2013150126A2/de active Application Filing
- 2013-04-05 ES ES13718522T patent/ES2773125T3/es active Active
- 2013-04-05 CN CN201810884744.2A patent/CN108926749A/zh active Pending
- 2013-04-05 ES ES17172222T patent/ES2938886T3/es active Active
-
2017
- 2017-02-15 US US15/433,143 patent/US10123530B2/en active Active
- 2017-07-10 JP JP2017134929A patent/JP6619394B2/ja active Active
-
2018
- 2018-10-23 US US16/167,615 patent/US10772321B2/en active Active
-
2019
- 2019-11-14 JP JP2019206147A patent/JP6997160B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DK3260865T5 (da) | 2024-10-14 |
| US20190037835A1 (en) | 2019-02-07 |
| ES2773125T3 (es) | 2020-07-09 |
| EP3260865A3 (de) | 2018-05-09 |
| EP3260865B1 (de) | 2022-12-28 |
| PL3260865T3 (pl) | 2023-04-11 |
| JP2015518474A (ja) | 2015-07-02 |
| EP2834643B1 (de) | 2019-10-23 |
| WO2013150126A2 (de) | 2013-10-10 |
| JP6997160B2 (ja) | 2022-02-03 |
| US20170172139A1 (en) | 2017-06-22 |
| CN104380110A (zh) | 2015-02-25 |
| CN108926749A (zh) | 2018-12-04 |
| EP2834643A2 (de) | 2015-02-11 |
| JP2020037582A (ja) | 2020-03-12 |
| US9591845B2 (en) | 2017-03-14 |
| JP6619394B2 (ja) | 2019-12-11 |
| EP3260865A2 (de) | 2017-12-27 |
| ES2938886T3 (es) | 2023-04-17 |
| US10123530B2 (en) | 2018-11-13 |
| WO2013150126A3 (de) | 2014-01-03 |
| DK2834643T3 (da) | 2020-02-03 |
| JP2017222682A (ja) | 2017-12-21 |
| US10772321B2 (en) | 2020-09-15 |
| US20150282477A1 (en) | 2015-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2838900T3 (da) | Forbindelser og fremgangsmåder til antiviral behandling | |
| DK3260865T5 (da) | Fremgangsmåde til behandling af blod, blodprodukter og organer | |
| DK2931143T3 (da) | Implantat og føring til kæbe-ansigts-kirurgi | |
| EP2890440A4 (en) | DEVICES AND METHOD FOR THE TREATMENT OF VASCULAR DISEASES | |
| DK3024497T3 (da) | Fremgangsmåder og præparater til behandling af hjernesygdomme | |
| DK3444342T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af lysosomale aflejringssygdomme | |
| DK3295942T3 (da) | Kombinationer omfattende 5-phenoxy-3h-pyrimidin-4-on-derivater og anvendelse heraf til profylakse eller behandling af hiv-infektion | |
| DK3473278T3 (da) | Fremgangsmåde til enzymatisk behandling af vævsprodukter | |
| ZA201402948B (en) | Mobile treatment, diagnostic and minor surgery facility | |
| DK2726511T3 (da) | Sammensætninger, anvendelser og fremgangsmåder til behandling af stofskiftesygdomme og -lidelser | |
| DK3202305T3 (da) | Engangsendoskop og system | |
| DK2720617T4 (da) | Vævsbeholder / beholderaggregat og dertil knyttet fremgangsmåde. | |
| BR112013018469A2 (pt) | dispositivos e métodos para tratamento de tecidos | |
| SG10201800720YA (en) | Blood treatment systems and methods | |
| EP2879617A4 (en) | DEVICES AND METHOD FOR THE TREATMENT OF EYE ARTERY CLOSURE | |
| BR112014020761A2 (pt) | Aparelho médico e método | |
| DK2861273T3 (da) | Anvendelse af heparin og kulhydrater til behandling af cancer. | |
| DK2903967T6 (da) | Acylaminopyrimidinderivater til behandling af virusinfektioner og andre sygdomme | |
| DK2765966T3 (da) | System, interfaceanordninger, anvendelse af interfaceanordningerne og fremgangsmåde til øjenkirurgi | |
| DK2764881T3 (da) | System til medicinsk behandling | |
| BR112017002074A2 (pt) | vestuário e método de compressão médica terapêutica | |
| PT2911716T (pt) | Dispositivo de tratamento extracorporal do sangue | |
| PL2644215T3 (pl) | Aparat do pozaustrojowej obróbki krwi | |
| DK2800575T3 (da) | Behandling af subarachnoidalblødning og iskæmi | |
| GB201207543D0 (en) | Treatment of transfusion blood |